CBAY Quote, Trading Chart, CymaBay Therapeutics Inc.
home / stock / cbay / cbay quote
$4.72 Last:
1.94% Change Percent:
$4.64 Open:
$4.72 Previous Close:
$4.84 High:
$4.56 Low:
662,176 Volume:
06/21/2021 04:42:43 am Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
CBAY Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-06-21 | 4.64 | 4.72 | 4.84 | 4.56 | 662,176 |
| 2021-06-18 | 4.87 | 4.63 | 4.8902 | 4.58 | 833,213 |
| 2021-06-17 | 4.8 | 4.92 | 4.94 | 4.78 | 548,553 |
| 2021-06-16 | 4.8516 | 4.79 | 4.92 | 4.68 | 691,447 |
| 2021-06-15 | 4.95 | 4.89 | 4.95 | 4.71 | 840,601 |
| 2021-06-14 | 4.7826 | 4.9 | 5.06 | 4.7826 | 921,277 |
| 2021-06-11 | 4.6626 | 4.68 | 4.815 | 4.625 | 648,823 |
| 2021-06-10 | 4.651 | 4.67 | 4.7 | 4.56 | 485,822 |
| 2021-06-09 | 4.69 | 4.62 | 4.8 | 4.54 | 763,605 |
| 2021-06-08 | 4.9711 | 4.67 | 5.03 | 4.6 | 1,034,103 |
| 2021-06-07 | 4.29 | 4.84 | 5 | 4.25 | 1,610,960 |
| 2021-06-04 | 4.34 | 4.27 | 4.35 | 4.15 | 984,199 |
| 2021-06-03 | 4.3066 | 4.34 | 4.36 | 4.24 | 524,014 |
| 2021-06-02 | 4.39 | 4.27 | 4.55 | 4.22 | 732,670 |
| 2021-06-01 | 4.2503 | 4.38 | 4.42 | 4.18 | 941,102 |
| 2021-05-31 | 4.25 | 4.23 | 4.38 | 4.18 | 552,174 |
| 2021-05-28 | 4.25 | 4.23 | 4.38 | 4.18 | 551,983 |
| 2021-05-27 | 4.48 | 4.21 | 4.48 | 4.2 | 1,725,466 |
| 2021-05-26 | 4.2145 | 4.49 | 4.58 | 4.18 | 1,864,811 |
| 2021-05-25 | 4.38 | 4.18 | 4.47 | 4.15 | 750,657 |
CymaBay Therapeutics Inc. Company Name:
CBAY Stock Symbol:
NASDAQ Market:
CymaBay Therapeutics Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
-
New analyses adds to the growing body of evidence for seladelpar’s potential as a treatment for patients with PBC NEWARK, Calif., June 21, 2021 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on develop...
-
CBAY - CymaBay Therapeutics Announces Presentations During The International Liver Congress(TM) 2021
NEWARK, Calif., June 09, 2021 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, today announced that multiple seladelpar presentations will be d...
-
Image source: The Motley Fool. CymaBay Therapeutics Inc. (NASDAQ: CBAY) Q1 2021 Earnings Call May 13, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: CymaBay Therapeutics Inc. (CBAY) Q1 2021 Earnings Call Transcript...